Intensity Therapeutics, Inc.

INTS

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/27/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report06/16/26 8-KCurrent report05/07/26 8-KCurrent report03/27/26 8-KCurrent report03/23/26

Prospectuses and Registrations

S-8Registration of securities for employees07/08/26 424B5Prospectus supplement03/23/26 S-8Registration of securities for employees01/23/26 424B5Prospectus supplement12/04/25 424B5Prospectus supplement11/03/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy09/09/25 DEFA14AAdditional proxy materials09/09/25 PRE 14APreliminary proxy08/28/25

Ownership

Form 4Insider transaction07/20/26 Form 4Insider transaction07/20/26 Form 4Insider transaction07/20/26 Form 4Insider transaction07/20/26 Form 4Insider transaction07/20/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders06/02/25 EFFECTRequest for effectiveness04/24/25 CORRESPCorrespondence with the SEC04/22/25 UPLOADLetter from the SEC04/02/25